These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1358585)

  • 1. Trimethadione metabolism as an index of hepatic drug-oxidizing capacity in dogs with liver ischemia.
    Tanaka E; Otsuka M; Yuzawa K; Isikawa A; Fukao K; Iwasaki Y
    Drug Metab Dispos; 1992; 20(5):773-4. PubMed ID: 1358585
    [No Abstract]   [Full Text] [Related]  

  • 2. Trimethadione: metabolism and assessment of hepatic drug-oxidizing capacity.
    Tanaka E; Funae Y
    Methods Enzymol; 1996; 272():163-9. PubMed ID: 8791774
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatic trimethadione-oxidizing capacity remains normal in patients with extrahepatic cholelithiasis.
    Tanaka E; Ishikawa A; Ono A; Takada A; Okamura T; Misawa S
    J Pharmacobiodyn; 1986 May; 9(5):506-9. PubMed ID: 3761137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethadione metabolism as a probe drug to estimate hepatic oxidizing capacity in rats.
    Tanaka E; Ishikawa A; Kobayashi S; Yasuhara H; Misawa S; Kuroiwa Y
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Feb; 104(2):205-7. PubMed ID: 8098675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of short-term administration of ibuprofen on trimethadione metabolism and antipyrine metabolite formation in the rat.
    Tanaka E; Kobayashi S; Oguchi K; Kuroiwa Y; Yasuhara H
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):317-20. PubMed ID: 4023417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of selective cytochrome P-450 inducing agents on trimethadione metabolism as an indicator of hepatic drug-oxidizing capacity in rats.
    Tanaka E; Etoh H; Misawa S
    Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):375-8. PubMed ID: 2385760
    [No Abstract]   [Full Text] [Related]  

  • 7. Pancreatic excretion of dimethadione and trimethadione by repeated oral administration of trimethadione in dogs.
    Noda A; Okumura I; Kato H; Ibuki E; Tamada M; Watanabe T
    Digestion; 1990; 46(1):19-26. PubMed ID: 2210093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified approach for determination of hepatic drug-oxidizing capacity using trimethadione metabolism as an indicator.
    Tanaka E; Kobayashi S; Nakamura K; Uchida E; Yasuhara H
    Biopharm Drug Dispos; 1989; 10(6):617-20. PubMed ID: 2611361
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between trimethadione metabolism and hepatic drug-oxidizing enzyme activities in different animal species.
    Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
    J Pharmacobiodyn; 1983 Jul; 6(7):481-6. PubMed ID: 6644533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of allyl alcohol and bromobenzene on trimethadione metabolism in the rat.
    Tanaka E; Nakamura T; Misawa S; Yoshida T; Kuroiwa Y
    Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):137-51. PubMed ID: 6473897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method for estimation of hepatic drug-metabolizing capacity: determination of concentration of trimethadione and its metabolite in human serum.
    Kobayashi S; Tanaka E; Oguchi K; Yoshida T; Kuroiwa Y; Yasuhara H
    J Pharmacobiodyn; 1984 May; 7(5):329-35. PubMed ID: 6470930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethadione as a model drug for the evaluation of hepatic drug-metabolizing capacity in normal and D-galactosamine intoxicated rats.
    Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
    Jpn J Pharmacol; 1982 Dec; 32(6):1182-5. PubMed ID: 7161969
    [No Abstract]   [Full Text] [Related]  

  • 13. Trimethadione metabolism in patients with normal liver and in patients with chronic liver disease.
    Tanaka E; Ishikawa A; Ono A; Okamura T; Misawa S
    J Pharmacobiodyn; 1987 Sep; 10(9):499-502. PubMed ID: 2830397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetic study of trimethadione and dimethadione for lysis of pancreatic stones.
    Noda A; Yamamoto K; Nakanishi Y
    Gastroenterol Jpn; 1986 Apr; 21(2):167-71. PubMed ID: 3710055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of organic solvents on trimethadione n-demethylation in rats.
    Nishimura Y; Kurata N; Iwase M; Li H; Yasuhara H
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):229-39. PubMed ID: 10634315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-independent pharmacokinetics of trimethadione and its metabolite in rats.
    Tanaka E; Yoshida T; Kuroiwa Y
    J Pharm Sci; 1985 Mar; 74(3):340-1. PubMed ID: 4009447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethadione as a probe drug to estimate hepatic oxidizing capacity in humans.
    Tanaka E; Ishikawa A; Abei M; Kobayashi S
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1996 Nov; 115(3):211-6. PubMed ID: 9375358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of trimethadione and its metabolite in blood, liver and brain by microdialysis in conscious, unrestrained rats.
    Kurata N; Inagaki M; Iwase M; Nishimura Y; Kiuchi Y; Yamazaki Y; Kobayashi S; Oguchi K; Uchida E; Yasuhara H
    Res Commun Mol Pathol Pharmacol; 1995 Jul; 89(1):45-56. PubMed ID: 7582861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethadione N-demethylation by rat liver CYP2E1 in vitro.
    Nishimura Y; Kurata N; Watanabe M; Uchida E; Yasuhara H
    Res Commun Mol Pathol Pharmacol; 1996 Jul; 93(1):43-56. PubMed ID: 8865369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in amino acid clearance during ischemia predict hepatocellular ATP changes.
    Fath JJ; St Cyr JA; Konstantinides FN; Alden P; Ascher NL; Bianco RW; Foker JE; Cerra FB
    Surgery; 1985 Sep; 98(3):396-404. PubMed ID: 4035562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.